National Bio Industries
Pharmaceutical & Health Products · Lobbying Client
C
Influence Score
47/100
Moderate Influence
$1.7M
Total Lobby Spend
6
Policy Issues
1
Lobbyists
0
Revolving Door
National Bio Industries reported $1.7 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Treasury
Dept of Justice
Dept of State
Dept of Health & Human Services
Dept of Agriculture
Environmental Protection Agency
White House
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Holland & Knight LLP | GOVAPPHCR+1 | 1 | $89K |
| 2020 Apr-Jun | Holland & Knight LLP | HCRGOVINS+1 | 1 | $64K |
| 2020 Jul-Sep | Cassidy & Associates LLP | HCRINSPHA | 1 | $93K |
| 2020 Oct-Dec | K&L Gates LLP | PHAMEDAPP+1 | 1 | $74K |
| 2021 Jan-Mar | Cassidy & Associates LLP | INSPHA | 1 | $88K |
| 2021 Apr-Jun | Brownstein Hyatt LLP | APP | 1 | $85K |
| 2021 Jul-Sep | Holland & Knight LLP | HCR | 1 | $108K |
| 2021 Oct-Dec | Cassidy & Associates LLP | GOVINSPHA+1 | 1 | $71K |